Skip to main content
Eleni Andreopoulou, MD, Oncology, New York, NY

EleniAndreopoulouMD

Oncology New York, NY

Breast Cancer, Hematologic Oncology

Professor of Medicine, Weill Cornell College of Medicine/ New York Presbyterian Hospital- Director of Breast Cancer Clinical Research

Dr. Andreopoulou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Andreopoulou's full profile

Already have an account?

  • Office

    1283 York Avenue
    New York, NY 10065

Summary

  • I am a Professor of Medicine and the Director of Breast Cancer Clinical Research at Weill Cornell Medicine/NewYork-Presbyterian Hospital where I specialize in the personalized multidisciplinary care and treatment of patients with breast cancer. I am also a member of the Englander Institute for Precision Medicine at Cornell. I previously held faculty positions at the Albert Einstein College of Medicine/ Montefiore Medical Center and the University of Texas M.D. Anderson Cancer Center. I completed my training in major academic institutions in both Europe and the U.S., including St Bartholomew’s Hospital and the Royal Marsden Hospital/Institute of Cancer Research in London, UK and the New York University School of Medicine. I was a European Society of Medical Oncology fellow. I have a special interest in individualization of patient treatment and particularly in caring for women with aggressive breast cancer. My main research interest involves precision medicine to fast-track the drug development of biologics and targeted therapy that exploit our knowledge of the cancer genome and the immuno cell network for immunotherapy in order to effectively manage, treat and cure breast cancer. I am involved with all phases of clinical drug development in all stages of the disease and I especially focus on innovative clinical trial design that incorporates cutting-edge technology.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
  • University of Ioannina Faculty of Medicine
    University of Ioannina Faculty of MedicineClass of 1994, MD, Cum Laude

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2026
  • TX State Medical License
    TX State Medical License 2008 - 2011
  • ECFMG

Awards, Honors, & Recognition

  • Assistant Professor of Medicine, Department of Breast Medical Oncology UT. MD Anderson Cancer Center, 2007-2010
  • European Society of Medical Oncology (ESMO) Fellowship Royal Marsden Hospital/ Institute of Cancer Research, London, England

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer
    Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
  • EMBCA Presents Evolution of Pharma and Biotech Industry in the 21st Century
    EMBCA Presents Evolution of Pharma and Biotech Industry in the 21st CenturyNovember 23rd, 2019
  • One-Way Texting: No Help with Breast Cancer Pill Taking, But…
    One-Way Texting: No Help with Breast Cancer Pill Taking, But…July 25th, 2019

Professional Memberships

Other Languages

  • Greek